 John Koeppe
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 11 | 2014 | 2469 | 0.930 |
Why?
| | Pain | 3 | 2013 | 705 | 0.790 |
Why?
| | Analgesics | 2 | 2012 | 158 | 0.690 |
Why?
| | Analgesics, Opioid | 2 | 2013 | 771 | 0.470 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2012 | 256 | 0.400 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2010 | 5 | 0.360 |
Why?
| | Mycobacterium avium Complex | 1 | 2010 | 92 | 0.330 |
Why?
| | Viral Proteins | 2 | 2011 | 281 | 0.300 |
Why?
| | Chronic Pain | 1 | 2012 | 210 | 0.300 |
Why?
| | HIV-1 | 3 | 2014 | 768 | 0.300 |
Why?
| | HIV Core Protein p24 | 2 | 2006 | 28 | 0.280 |
Why?
| | Interferon-gamma | 2 | 2010 | 719 | 0.270 |
Why?
| | Delivery of Health Care | 1 | 2013 | 833 | 0.270 |
Why?
| | HIV Antigens | 1 | 2006 | 17 | 0.260 |
Why?
| | Gene Products, gag | 1 | 2006 | 36 | 0.260 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2006 | 170 | 0.250 |
Why?
| | Viremia | 1 | 2006 | 122 | 0.240 |
Why?
| | Hospitalization | 1 | 2013 | 1752 | 0.240 |
Why?
| | Mycobacterium avium | 1 | 2004 | 21 | 0.230 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2004 | 17 | 0.230 |
Why?
| | Multivariate Analysis | 3 | 2013 | 1430 | 0.230 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2006 | 959 | 0.220 |
Why?
| | Peritonitis | 1 | 2004 | 77 | 0.220 |
Why?
| | Emergency Service, Hospital | 1 | 2013 | 1815 | 0.210 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2004 | 63 | 0.210 |
Why?
| | Middle Aged | 12 | 2014 | 26737 | 0.160 |
Why?
| | Pain Measurement | 2 | 2012 | 444 | 0.160 |
Why?
| | Adult | 8 | 2014 | 30550 | 0.120 |
Why?
| | Male | 10 | 2014 | 55596 | 0.110 |
Why?
| | CD4 Lymphocyte Count | 2 | 2011 | 257 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2006 | 2096 | 0.100 |
Why?
| | Viral Load | 2 | 2011 | 405 | 0.100 |
Why?
| | Drug Therapy, Combination | 2 | 2006 | 951 | 0.100 |
Why?
| | Movement | 1 | 2014 | 244 | 0.100 |
Why?
| | Female | 9 | 2013 | 59507 | 0.100 |
Why?
| | Humans | 14 | 2014 | 114686 | 0.090 |
Why?
| | Interleukin-12 | 1 | 2010 | 110 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2539 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2014 | 532 | 0.080 |
Why?
| | Chronic Disease | 3 | 2010 | 1578 | 0.080 |
Why?
| | Odds Ratio | 1 | 2012 | 953 | 0.080 |
Why?
| | Databases, Factual | 1 | 2013 | 1125 | 0.080 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 19 | 0.080 |
Why?
| | Logistic Models | 1 | 2013 | 1841 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2010 | 4411 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1075 | 0.080 |
Why?
| | Outpatients | 1 | 2011 | 326 | 0.080 |
Why?
| | Bacteria | 1 | 2014 | 725 | 0.070 |
Why?
| | Cross-Sectional Studies | 2 | 2010 | 4409 | 0.070 |
Why?
| | HIV-Associated Lipodystrophy Syndrome | 1 | 2007 | 17 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 493 | 0.070 |
Why?
| | Risk Factors | 2 | 2011 | 8632 | 0.070 |
Why?
| | Basal Metabolism | 1 | 2007 | 46 | 0.070 |
Why?
| | HIV | 1 | 2008 | 208 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 2007 | 72 | 0.070 |
Why?
| | Lipodystrophy | 1 | 2007 | 16 | 0.070 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 12 | 0.070 |
Why?
| | Glyburide | 1 | 2006 | 35 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2010 | 578 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1078 | 0.060 |
Why?
| | Caloric Restriction | 1 | 2007 | 90 | 0.060 |
Why?
| | Anti-HIV Agents | 1 | 2011 | 666 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2006 | 1982 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2012 | 12550 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2387 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2006 | 323 | 0.060 |
Why?
| | Energy Metabolism | 2 | 2007 | 731 | 0.060 |
Why?
| | Energy Intake | 1 | 2007 | 427 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2012 | 9088 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2006 | 2785 | 0.060 |
Why?
| | Aging | 1 | 2014 | 1618 | 0.060 |
Why?
| | Immunocompetence | 1 | 2004 | 40 | 0.060 |
Why?
| | Lung Diseases, Interstitial | 1 | 2008 | 508 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 371 | 0.050 |
Why?
| | Metformin | 1 | 2006 | 276 | 0.050 |
Why?
| | Cohort Studies | 1 | 2011 | 4895 | 0.050 |
Why?
| | Genetic Variation | 1 | 2006 | 870 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2006 | 1013 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2006 | 3886 | 0.040 |
Why?
| | Calorimetry, Indirect | 2 | 2007 | 69 | 0.040 |
Why?
| | Laryngeal Neoplasms | 1 | 1996 | 27 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 1996 | 89 | 0.030 |
Why?
| | Oncogene Proteins | 1 | 1996 | 53 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 1996 | 90 | 0.030 |
Why?
| | Risk Assessment | 1 | 2004 | 2968 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1481 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1996 | 523 | 0.030 |
Why?
| | Adipose Tissue | 2 | 2007 | 545 | 0.030 |
Why?
| | Body Composition | 2 | 2007 | 590 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1996 | 445 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1996 | 577 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 1996 | 1040 | 0.020 |
Why?
| | Erlotinib Hydrochloride | 1 | 2008 | 64 | 0.020 |
Why?
| | Postprandial Period | 1 | 2007 | 87 | 0.020 |
Why?
| | Quinazolines | 1 | 2008 | 240 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2006 | 41 | 0.020 |
Why?
| | Fluorides | 1 | 2006 | 43 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2007 | 117 | 0.020 |
Why?
| | Polyurethanes | 1 | 2006 | 34 | 0.020 |
Why?
| | Phenotype | 1 | 2014 | 2796 | 0.020 |
Why?
| | Methacrylates | 1 | 2006 | 106 | 0.020 |
Why?
| | Prognosis | 2 | 2008 | 3329 | 0.020 |
Why?
| | Triglycerides | 1 | 2007 | 467 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2008 | 554 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2320 | 0.020 |
Why?
| | Eating | 1 | 2007 | 344 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2007 | 1226 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2008 | 1342 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 3408 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2007 | 483 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2480 | 0.010 |
Why?
| | RNA, Viral | 1 | 2006 | 565 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 789 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 785 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2380 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 1959 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 10469 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 3346 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 17844 | 0.010 |
Why?
| | Larynx | 1 | 1996 | 47 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1996 | 134 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 1996 | 321 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1996 | 1167 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1996 | 1629 | 0.010 |
Why?
| | Gene Expression | 1 | 1996 | 1421 | 0.010 |
Why?
| | Apoptosis | 1 | 1996 | 2363 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 6347 | 0.000 |
Why?
| | Prospective Studies | 1 | 1996 | 6220 | 0.000 |
Why?
| | Aged | 1 | 1996 | 19074 | 0.000 |
Why?
|
|
Koeppe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|